100 related articles for article (PubMed ID: 35140436)
1. Clinical Profile of COVID-19 Patients Admitted in a COVID Designated Hospital.
Ghimire P; Pokharel A; Aryal P; Bhandari R; Bhandari B
J Nepal Health Res Counc; 2021 Dec; 19(3):587-595. PubMed ID: 35140436
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
[TBL] [Abstract][Full Text] [Related]
6. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
[TBL] [Abstract][Full Text] [Related]
8. [COVID-19 pneumonia. Experience of a public hospital in Argentina].
Sadonio MJ; Castro MG; Castillo A; Ramos L; Cuevas G; Galluccio F
Medicina (B Aires); 2021; 81(6):908-915. PubMed ID: 34875587
[TBL] [Abstract][Full Text] [Related]
9. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study.
Scarpa R; Dell'Edera A; Felice C; Buso R; Muscianisi F; Finco Gambier R; Toffolo S; Grossi U; Giobbia M; Barberio G; Landini N; Facchini C; Agostini C; Rattazzi M; Cinetto F
Front Immunol; 2022; 13():842643. PubMed ID: 35359947
[TBL] [Abstract][Full Text] [Related]
11. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.
Afriyie-Mensah J; Aboagye ET; Ganu VJ; Bondzi S; Tetteh D; Kwarteng E; Akamah J; Doku A; Adjei P
Pan Afr Med J; 2021; 38():107. PubMed ID: 33912277
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and outcome analysis of SARS-CoV-2 patients admitted to different Critical Care Units in Nepal.
Hamal PK; Poudel PR; Yadav RK; Sigdel R; Chapagai B; Bhattarai R; Bhandari TR; Jha PK; Yadav S; Neupane AP; Ghimire S; Poudel K; Dhungana S; Pokharel N; Dhakal GR; Gyanwali P
J Nepal Health Res Counc; 2022 Jun; 20(1):47-53. PubMed ID: 35945852
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Elevated D-dimer Levels in Confirmed COVID-19 Cases in Intensive Care Unit of a Tertiary Care Centre of Western Nepal.
Khatri P; Agrawal KK; Sharma D; Chhetri P; Neupane A; Piryani RM; Baral PP; Sapkota SR; Banjade A; Chhetri A; Bhandari S; Bharali S
JNMA J Nepal Med Assoc; 2021 Mar; 59(235):243-247. PubMed ID: 34506437
[TBL] [Abstract][Full Text] [Related]
14. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study.
Ñamendys-Silva SA; Alvarado-Ávila PE; Domínguez-Cherit G; Rivero-Sigarroa E; Sánchez-Hurtado LA; Gutiérrez-Villaseñor A; Romero-González JP; Rodríguez-Bautista H; García-Briones A; Garnica-Camacho CE; Cruz-Ruiz NG; González-Herrera MO; García-Guillén FJ; Guerrero-Gutiérrez MA; Salmerón-González JD; Romero-Gutiérrez L; Canto-Castro JL; Cervantes VH;
Heart Lung; 2021; 50(1):28-32. PubMed ID: 33138974
[TBL] [Abstract][Full Text] [Related]
16. [Convalescent plasma therapy in COVID-19 patients, in the Province of Buenos Aires].
González SE; Regairaz L; Ferrando NS; González Martínez VV; Salazar MR; Estenssoro E
Medicina (B Aires); 2020; 80(5):417-424. PubMed ID: 33048783
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial.
Mammen JJ; Kumar S; Thomas L; Kumar G; Zachariah A; Jeyaseelan L; Peter JV; Agarwal A; Mukherjee A; Chatterjee P; Bhatnagar T; Rasalam JE; Chacko B; Mani T; Joy M; Rupali P; Murugesan M; Daniel D; Latha B; Bundas S; Kumar V; Dosi R; Khambholja JR; de Souza R; Chander BT; Bahadur S; Dube S; Suri A; Jindal A; Shrivastav O; Barge V; Bajpayee A; Malhotra P; Singh N; Tambe M; Sharma N; Bhat S; Kaulgud RS; Gurtoo A; Reddy DH; Upadhyay K; Jain A; Patel TC; Nagori I; Jha PR; Babu KVS; Aparna C; Panjwani SJ; Natarajan M; Baldi M; Khadke VK; Dua S; Singh R; Sharma A; Sharma J; Gokhale YA; Yadav PD; Sapkal G; Kaushal H; Kumar VS
BMJ Open; 2021 Oct; 11(10):e050571. PubMed ID: 34607865
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis.
Ismail K; Bensasi H; Taha A; Nazir A; Abdelkhalek M; Mohamed W; Lodhe D; Buschbeck S; Bauer M; Sakr Y
PLoS One; 2021; 16(10):e0251687. PubMed ID: 34679109
[TBL] [Abstract][Full Text] [Related]
19. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 subphenotypes at hospital admission are associated with mortality: a cross-sectional study.
Dubowski K; Braganza GT; Bozack A; Colicino E; DeFelice N; McGuinn L; Maru D; Lee AG
Ann Med; 2023 Dec; 55(1):12-23. PubMed ID: 36444856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
